06 DEC 2017
Thank you for taking the time to email me about breast cancer.
I understand you would like me to sign EDM 416 on this matter, however like many MPs I do not sign any EDMs no matter how worthy the cause. This is because EDMs now cost a huge amount per year to administer and have no chance of changing the Law. They are in effect petitions which only MPs can sign. They have also been superseded by online petitions which can be on any issue for which the Government or Parliament is responsible and any which receive 10,000 signatures will receive a response from the Government. Those petitions which reach 100,000 signatures will almost always be debated in Parliament – unless it is an issue which has recently been debated. There are also concerns that EDMs may give a false impression that action is being taken.
Nonetheless, I hope the following information on this topic from the Department of Health is of interest:
It is important that every effort is made to continue raising awareness of breast cancer, and tackle this disease, which has taken so many lives over the years.
In 2015, Public Health England launched Be Clear on Cancer, a national scheme which has significantly improved awareness of breast cancer in women over 70, who account for roughly 1 in 3 cases of breast cancer. This has contributed to improved diagnosis and treatment of breast cancer. Breast cancer survival rates have improved remarkably over the last 40 years, and this is testament to the efforts made to raise awareness of cancer, promote healthy lifestyles, and boost funding into tackling this disease.
Ministers are making great efforts to improve cancer services, and ensure that the NHS provides some of the world's best cancer care. The NHS has launched the National Cancer Programme which is committed to offering uniquely tailored cancer treatment to all patients with breast cancer by 2020 It is working closely with Health Education England and Macmillan Cancer Support to understand the best ways developing and implementing cancer services by the same date.
The National Institute for Health and Care Excellence (NICE) is updating its guidelines on the diagnosis and management of breast cancer. These guidelines will cover the use of adjuvant bisphosphonates and other cancer drugs, and will be published in July 2018.
Regarding the age at which mandatory mammograms are offered by the NHS. Mandatory mammograms play a key part in the early diagnosis of breast cancer, which is central to the Government's ambition of achieving world-class cancer outcomes. The breast cancer screening programme is currently offered to all women between the ages of 50 and 70. You may be encouraged to hear that the NHS is trialling expanding compulsory screening to women aged between 47 and 73. This trial began in 2009 and is expected to run until the mid-2020s, until the NHS has sufficient information to understand its effectiveness. Figures from Cancer Research UK show a significant increase in the incidence of breast cancer in women in their mid-40s, and very low rates of occurrence in those under the age of 30. It is appropriate that the NHS is looking at expanding the screening process, whilst ensuring resources are allocated wisely, and directed towards those women most likely to be at risk of contracting breast cancer.
These developments will significantly improve patient experience and quality of care. The NHS is implementing the independent Cancer Taskforce's recommendation that all breast cancer patients shall receive access to a Clinical Nurse Specialist, or other key workers. This will enable greater detection of any recurrence or secondary breast cancer, and enable a quick and effective return to care.
This is part of the NHS's ambitious wider strategy to improve cancer outcomes, and save 30,000 lives per year by 2020.
Back to all posts